{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:03:54Z","timestamp":1783350234952,"version":"3.54.6"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,17]]},"DOI":"10.7759\/cureus.10507","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T16:53:15Z","timestamp":1600361595000},"source":"Crossref","is-referenced-by-count":3,"title":["Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report"],"prefix":"10.7759","author":[{"given":"Joel","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Aster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah S","family":"Millstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: a comprehensive clinical review","volume":"67","author":"Salter BS","year":"2016","unstructured":"Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, Fischer GW. Heparin-induced thrombocytopenia: a comprehensive clinical review. J Am Coll Cardiol. 2016, 67:2519-2532. 10.1016\/j.jacc.2016.02.073","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster RH","year":"2009","unstructured":"Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009, 7:911-918. 10.1111\/j.1538-7836.2009.03360.x","journal-title":"J Thromb Haemost"},{"key":"ref3","unstructured":"FDA updates warnings for fluoroquinolone antibiotics. Limits use for acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis and uncomplicated urinary tract infections. (2016). Accessed: July 16, 2020: http:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-warnings-fluoroquinolone-antibiotics."},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-245","article-title":"Detection and identification of platelet antibodies and antigens in the clinical laboratory","volume":"25","author":"Curtis BR","year":"2009","unstructured":"Curtis BR, McFarland JG. Detection and identification of platelet antibodies and antigens in the clinical laboratory. Immunohematology. 2009, 25:125-135.","journal-title":"Immunohematology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-0734.2001.00041.x","article-title":"Drug-induced and drug-dependent immune thrombocytopenias","volume":"5","author":"Greinacher A","year":"2001","unstructured":"Greinacher A, Eichler P, Lubenow N, Kiefel V. Drug-induced and drug-dependent immune thrombocytopenias. Rev Clin Exp Hematol. 2001, 5:166-312. 10.1046\/j.1468-0734.2001.00041.x","journal-title":"Rev Clin Exp Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.05.005","article-title":"Approach to the diagnosis and management of drug-induced immune thrombocytopenia","volume":"27","author":"Arnold DM","year":"2013","unstructured":"Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013, 27:137-145. 10.1016\/j.tmrv.2013.05.005","journal-title":"Transfus Med Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0037-1963(00)90101-x","article-title":"Can drugs cause autoimmune thrombocytopenic purpura?","volume":"37","author":"Aster RH","year":"2000","unstructured":"Aster RH. Can drugs cause autoimmune thrombocytopenic purpura?. Semin Hematol. 2000, 37:229-238. 10.1016\/s0037-1963(00)90101-x","journal-title":"Semin Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007501","article-title":"Drug-induced immune thrombocytopenia due to moxifloxacin","volume":"2013","author":"Coker TJ","year":"2013","unstructured":"Coker TJ. Drug-induced immune thrombocytopenia due to moxifloxacin. BMJ Case Rep. 2013, 2013:bcr2012007501. 10.1136\/bcr-2012-007501","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/459140","article-title":"Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura","volume":"2012","author":"Surana SP","year":"2012","unstructured":"Surana SP, Sardinas Z, Multz AS. Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura. Case Rep Med. 2012, 2012:459140. 10.1155\/2012\/459140","journal-title":"Case Rep Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014529929","article-title":"Moxifloxacin-induced immune-mediated thrombocytopenia in a chronic kidney disease patient receiving hemodialysis","volume":"48","author":"Mailman JF","year":"2014","unstructured":"Mailman JF, Stigant C, Martinusen D. Moxifloxacin-induced immune-mediated thrombocytopenia in a chronic kidney disease patient receiving hemodialysis. Ann Pharmacother. 2014, 48:919-922. 10.1177\/1060028014529929","journal-title":"Ann Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5578\/tt.10649","article-title":"Moxifloxacin-related thrombocytopenia: a case report","volume":"64","author":"\u00c7\u00f6rt\u00fck M","year":"2016","unstructured":"\u00c7\u00f6rt\u00fck M, Benli AR, K\u00f6ro\u011flu M, Yaz\u0131c\u0131 O, Acat M, Casim H, \u00c7etinkaya E. Moxifloxacin-related thrombocytopenia: a case report. Tuberk Toraks. 2016, 64:250-252. 10.5578\/tt.10649","journal-title":"Tuberk Toraks"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2009.01996.x","article-title":"Fluoroquinolone-induced immune thrombocytopenia: a report and review","volume":"39","author":"Cheah CY","year":"2009","unstructured":"Cheah CY, De Keulenaer B, Leahy MF. Fluoroquinolone-induced immune thrombocytopenia: a report and review. Intern Med J. 2009, 39:619-623. 10.1111\/j.1445-5994.2009.01996.x","journal-title":"Intern Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-643148","article-title":"Mechanism of quinine-dependent antibody bind to platelet glycoprotein GPIIb\/IIIa\/","volume":"126","author":"Bougie DW","year":"2015","unstructured":"Bougie DW, Peterson J, Rasmussen M, Aster RH. Mechanism of quinine-dependent antibody bind to platelet glycoprotein GPIIb\/IIIa\/. Blood. 2015, 126:2146-2152. 10.1182\/blood-2015-04-643148","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-639351","article-title":"Structural basis for quinine-dependent antibody binding to platelet integrin \u03b1IIb\u03b23","volume":"126","author":"Zhu J","year":"2015","unstructured":"Zhu J, Zhu J, Bougie DW, Aster RH, Springer TA. Structural basis for quinine-dependent antibody binding to platelet integrin \u03b1IIb\u03b23. Blood. 2015, 126:2138-2145. 10.1182\/blood-2015-04-639351","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-245. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/38671-moxifloxacin-induced-thrombocytopenia-mediated-by-moxifloxacin-dependent-igm-and-igg-antiplatelet-antibodies-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:43Z","timestamp":1707506563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/38671-moxifloxacin-induced-thrombocytopenia-mediated-by-moxifloxacin-dependent-igm-and-igg-antiplatelet-antibodies-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.10507","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,17]]}}}